Nesthege Gene Arcy
FDA investigator
Appears on 1 document from 2022, mostly at sites in North Carolina. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110).
- 1
- Documents on file
- 2.0
- Observations per 483
- 2022
- First seen
- 2022
- Most recent
What they cite most
From 2 observations- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
Activity by year
2022: 1
Where
North Carolina 1
Often inspects with
Is Nesthege Gene Arcy coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-05-06 | 483 Grifols Therapeutics LLCMay 6, 2022 · Clayton, North Carolina | Clayton, North Carolina | 2 |
About this profile
What does Nesthege Gene Arcy inspect?
Nesthege Gene Arcy appears on 1 document on file covering 1 site, mostly in North Carolina.
What do they cite most often?
21 CFR 211.110 (sampling and testing of in-process materials and drug products), followed by 21 CFR 211.113.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Nesthege Gene Arcy is dated May 6, 2022.